Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 221-230 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Predictors of Angiotensin-Converting Enzyme Inhibitor-Induced Reduction of Urinary Albumin Excretion in Nondiabetic Patients
Ruud M.A. van de Wal, Ron T. Gansevoort, Pim van der Harst, Frans Boomsma, H. W. Thijs Plokker, Dirk J. van Veldhuisen, Paul E. de Jong, Wiek H. van Gilst, and Adriaan A. Voors
Hypertension published September 25, 2006, doi:10.1161/01.HYP.0000244082.26293.2d [Abstract]  

Scientific Contributions
Changes in Antihypertensive Prescribing During US Outpatient Visits for Uncomplicated Hypertension Between 1993 and 2004
Jun Ma, Ky-Van Lee, and Randall S. Stafford
Hypertension published September 18, 2006, doi:10.1161/01.HYP.0000240931.90917.0c [Abstract]  

Editorial Commentary
Phosphodiesterase 5 Inhibition to Treat Essential Hypertension. Is This the Beginning of the Story?
Stefano Taddei and Lorenzo Ghiadoni
Hypertension published September 11, 2006, doi:10.1161/01.HYP.0000241985.54400.85 [Abstract]  

Editorial Commentaries
The Valsartan Antihypertensive Long-Term Use Evaluation Trial: A Study in Contrasts
Domenic A. Sica
Hypertension 2006;48:362-363; published online before print as doi:10.1161/01.HYP.0000236117.13311.0f [Full text]  

Original Articles
Tumor Necrosis Factor-{alpha} and Vascular Angiotensin II in Estrogen-Deficient Rats
Ivan A. Arenas, Stephen J. Armstrong, Yi Xu, and Sandra T. Davidge
Hypertension 2006;48:497-503; published online before print as doi:10.1161/01.HYP.0000235865.03528.f1 [Abstract] [Full text]  

Scientific Contributions
Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II
Jasper J. Saris, Peter A.C. ’t Hoen, Ingrid M. Garrelds, Dick H.W. Dekkers, Johan T. den Dunnen, Jos M.J. Lamers, and A. H. Jan Danser
Hypertension published August 28, 2006, doi:10.1161/01.HYP.0000240064.19301.1b [Abstract]  

Scientific Contributions
Effect of Regular Phosphodiesterase Type 5 Inhibition in Hypertension
James J. Oliver, Vanessa P. Melville, and David J. Webb
Hypertension published August 28, 2006, doi:10.1161/01.HYP.0000239816.13007.c9 [Abstract]  

Scientific Contributions
Sustained Normalization of High Blood Pressure in Spontaneously Hypertensive Rats by Implanted Hemin Pump
Rui Wang, Rany Shamloul, Xiaoxia Wang, Qinghe Meng, and Lingyun Wu
Hypertension published August 28, 2006, doi:10.1161/01.HYP.0000239673.80332.2f [Abstract]  

Editorial Commentaries
From Clinical Trials to Clinical Practice: Why the Gap?
Theodore A. Kotchen
Hypertension 2006;48:196-197; published online before print as doi:10.1161/01.HYP.0000229712.18111.b3 [Full text]  

Editorial Commentaries
Drospirenone: An Antihypertensive in Waiting
Domenic A. Sica
Hypertension 2006;48:205-206; published online before print as doi:10.1161/01.HYP.0000232180.72752.f8 [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment